cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - Антинеопластични средства - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
sohonos
ipsen pharma - palovarotene - myositis ossificans - Други лекарства за нарушения на мускулно-скелетната система - treatment of fibrodysplasia ossificans progressiva.
Диферелин 0,1mg прах и разтворител за инжекционен разтвор x 7
ipsen pharma - Трипторелин -
diphereline sr 3,75 mg powder and solvent for prolonged - release suspension for injection
ipsen pharma - Трипторелин - 3,75 mg powder and solvent for prolonged - release suspension for injection
diphereline sr 11,25 mg powder and solvent for prolonged - release suspension for injection
ipsen pharma - Трипторелин - 11,25 mg powder and solvent for prolonged - release suspension for injection
tanakan 40 mg/ml oral solution
ipsen pharma - Гинко билоба - 40 mg/ml oral solution
tanakan 40 mg film - coated tablets
ipsen pharma - Гинко билоба - 40 mg film - coated tablets